TY - JOUR
T1 - Challenges in the management of the kidney allograft
T2 - from decline to failure: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
AU - for Conference Participants
AU - Josephson, Michelle A.
AU - Becker, Yolanda
AU - Budde, Klemens
AU - Kasiske, Bertram L.
AU - Kiberd, Bryce A.
AU - Loupy, Alexandre
AU - Małyszko, Jolanta
AU - Mannon, Roslyn B.
AU - Tönshoff, Burkhard
AU - Cheung, Michael
AU - Jadoul, Michel
AU - Winkelmayer, Wolfgang C.
AU - Zeier, Martin
AU - Ahn, Curie
AU - Alberú, Josefina
AU - Baliker, Mary
AU - Bamgboye, Ebun L.
AU - Barber, Thelma
AU - Bensouda, Melissa
AU - Chadban, Steve J.
AU - Dadhania, Darshana M.
AU - Dębska-Ślizień, Alicja
AU - Devresse, Arnaud
AU - Ditzen, Beate
AU - Fowler, Kevin
AU - Gill, John S.
AU - Jha, Vivekanand
AU - Khairallah, Pascale
AU - Knoll, Greg A.
AU - Korst, Uwe
AU - Lee, Austin
AU - Legendre, Christophe
AU - Lentine, Krista L.
AU - Lerma, Edgar V.
AU - Lorenz, Elizabeth C.
AU - Matas, Arthur J.
AU - Mohan, Sumit
AU - Nazarewski, Sławomir
AU - Noronha, Irene L.
AU - Obrador, Gregorio T.
AU - Parekh, Rulan S.
AU - Pavlakis, Martha
AU - Pascual, Julio
AU - Pilmore, Helen L.
AU - Rosenkranz, Alexander R.
AU - Rozen-Zvi, Benaya
AU - Roy-Chaudhury, Prabir
AU - Tanabe, Kazunari
AU - Wanner, Christoph
AU - Wasse, Haimanot
N1 - Publisher Copyright:
© 2023 KDIGO: Kidney Disease Improving Global Outcomes
PY - 2023/12
Y1 - 2023/12
N2 - In March 2022, Kidney Disease: Improving Global Outcomes (KDIGO) held a virtual Controversies Conference to address the important but rarely examined phase during which the kidney transplant is failing or has failed. In addition to discussing the definition of a failing allograft, 4 broad areas were considered in the context of a declining functioning graft: prognosis and kidney failure trajectory; immunosuppression strategies; management of medical and psychological complications, and patient factors; and choice of kidney replacement therapy or supportive care following graft loss. Identifying and paying special attention to individuals with failing allografts was felt to be important in order to prepare patients psychologically, manage immunosuppression, address complications, prepare for dialysis and/or retransplantation, and transition to supportive care. Accurate prognostication tools, although not yet widely available, were embraced as necessary to define allograft survival trajectories and the likelihood of allograft failure. The decision of whether to withdraw or continue immunosuppression after allograft failure was deemed to be based most appropriately on risk–benefit analysis and likelihood of retransplantation within a few months. Psychological preparation and support was identified as a critical factor in patient adjustment to graft failure, as was early communication. Several models of care were noted that enabled a medically supportive transition back to dialysis or retransplantation. Emphasis was placed on the importance of dialysis-access readiness before initiation of dialysis, in order to avoid use of central venous catheters. The centrality of the patient to all management decisions and discussions was deemed to be paramount. Patient “activation,” which can be defined as engaged agency, was seen as the most effective way to achieve success. Unresolved controversies, gaps in knowledge, and areas for research were also stressed in the conference deliberations.
AB - In March 2022, Kidney Disease: Improving Global Outcomes (KDIGO) held a virtual Controversies Conference to address the important but rarely examined phase during which the kidney transplant is failing or has failed. In addition to discussing the definition of a failing allograft, 4 broad areas were considered in the context of a declining functioning graft: prognosis and kidney failure trajectory; immunosuppression strategies; management of medical and psychological complications, and patient factors; and choice of kidney replacement therapy or supportive care following graft loss. Identifying and paying special attention to individuals with failing allografts was felt to be important in order to prepare patients psychologically, manage immunosuppression, address complications, prepare for dialysis and/or retransplantation, and transition to supportive care. Accurate prognostication tools, although not yet widely available, were embraced as necessary to define allograft survival trajectories and the likelihood of allograft failure. The decision of whether to withdraw or continue immunosuppression after allograft failure was deemed to be based most appropriately on risk–benefit analysis and likelihood of retransplantation within a few months. Psychological preparation and support was identified as a critical factor in patient adjustment to graft failure, as was early communication. Several models of care were noted that enabled a medically supportive transition back to dialysis or retransplantation. Emphasis was placed on the importance of dialysis-access readiness before initiation of dialysis, in order to avoid use of central venous catheters. The centrality of the patient to all management decisions and discussions was deemed to be paramount. Patient “activation,” which can be defined as engaged agency, was seen as the most effective way to achieve success. Unresolved controversies, gaps in knowledge, and areas for research were also stressed in the conference deliberations.
KW - dialysis
KW - failing/failed graft
KW - immunosuppression
KW - medical complications
KW - psychological complications
KW - retransplantation
UR - http://www.scopus.com/inward/record.url?scp=85171529926&partnerID=8YFLogxK
U2 - 10.1016/j.kint.2023.05.010
DO - 10.1016/j.kint.2023.05.010
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 37236423
AN - SCOPUS:85171529926
SN - 0085-2538
VL - 104
SP - 1076
EP - 1091
JO - Kidney International
JF - Kidney International
IS - 6
ER -